Mauna Kea Technologies (STU:1MK) Cyclically Adjusted PB Ratio: (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:1MK Mauna Kea Technologies SA STU:1MK
47 GF Score
Price €0.16
GF Value €0.11
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Mauna Kea Technologies Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Mauna Kea Technologies  (STU:1MK) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Mauna Kea Technologies Cyclically Adjusted PB Ratio Related Terms


Mauna Kea Technologies Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Mauna Kea Technologies's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mauna Kea Technologies Cyclically Adjusted PB Ratio Chart

Mauna Kea Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.85 0.74 1.58 1.54 35.67

Mauna Kea Technologies Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.58 0.00 1.54 0.00 35.67

STU:1MK vs ABT, SYK, MDT: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Mauna Kea Technologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mauna Kea Technologies Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mauna Kea Technologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Mauna Kea Technologies's Cyclically Adjusted PB Ratio falls into.


STU:1MK
47GF Score
Mauna Kea Technologies SA STU:1MK
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mauna Kea Technologies Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Mauna Kea Technologies's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec25 is calculated as:

For example, Mauna Kea Technologies's adjusted Book Value per Share data for the fiscal year that ended in Dec25 was:

Adj_Book=Book Value per Share/CPI of Dec25 (Change)*Current CPI (Dec25)
=-0.027/120.9000*120.9000
=-0.027

Current CPI (Dec25) = 120.9000.

Mauna Kea Technologies Annual Data

Book Value per Share CPI Adj_Book
201612 0.558 100.650 0.670
201712 0.689 101.850 0.818
201812 0.317 103.470 0.370
201912 0.008 104.980 0.009
202012 -0.395 104.960 -0.455
202112 -0.232 107.850 -0.260
202212 -0.430 114.160 -0.455
202312 -0.281 118.390 -0.287
202412 -0.360 119.950 -0.363
202512 -0.027 120.900 -0.027

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Mauna Kea Technologies (STU:1MK) Overvalued in 2026?

Based on GuruFocus' analysis, Mauna Kea Technologies stock appears to be overvalued. The current stock price of €0.16 is trading 41.3% above its estimated GF Value™ of €0.11. GuruFocus considers Mauna Kea Technologies to be Significantly Overvalued.

Key valuation signals for STU:1MK:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €0.11 vs. price of €0.16 (41.3% above fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the STU:1MK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mauna Kea Technologies Business Description

Address 9 rue d\'Enghien, Paris, FRA, 75010
Mauna Kea Technologies SA is a medical device company that develops, manufactures and markets an imaging platform for visualizing tissue at the cellular level, in real time, during standard procedures, with the mission of eliminating uncertainties in diagnosis and treatment through direct visualization of tissue in vivo at the microscopic level. The company's flagship product, Cellvizio, is the smallest microscope, designed for direct use during minimally invasive procedures. It operates in a single business segment: endomicroscopy. Its geographical presence includes EMEA (Europe, Middle East, Africa), USA and Canada, and Asia, of which the majority of the revenue is generated from USA and Canada.
47GF Score

Get the complete analysis for STU:1MK

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.16
Price
€0.11
GF Value